Candel Therapeutics Inc. (NASDAQ: CADL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CANDEL THERAPEUTICS INC.

Candel Therapeutics Inc. (NASDAQ: CADL)
Listen to this Section


$8.53
-0.7450 ( -8.04% ) 1.3M

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Clinical Trial Pipeline Stages


Drug Name Stage
CAN-2409DetailsCancer, Solid tumor/s, Intermediate/high-risk Prostate cancerBig Mover™Suspected Mover™Susp. Mover™ Phase 3
CAN-2409DetailsCancer, Solid tumor/s, Low-to-intermediate-risk non-metastatic prostate cancer Phase 2b
CAN-2409 + Valacyclovir w/ SoCDetailsPancreatic cancer, Cancer Phase 2
CAN-2409 + Valacyclovir w/ PD-(L)1 targeting agentsDetailsLung cancer, Cancer, Solid tumor/s, Non-small cell lung carcinoma Phase 2
CAN-3110DetailsSolid tumor/s, Cancer, Glioma Phase 1b
CAN-2409 + OpdivoDetailsCancer, Glioma, Solid tumor/s Failed

Market Data


Open $8.53
Previous Close $9.27
Volume 1.3M
Market Cap $644.78M
Day Range $8.53 - $9.44
52 Week Range $4.35 - $9.57
Shares Outstanding 73.27M
Change % -8.04%
Net Change ▼ -0.7450
Insider Ownership -0.02%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States
UnderwriterJefferies, Credit Suisse, BMO Capital Markets, UBS Investment Bank, more

Insider Ownership Transactions

Total Amount Purchased: 74,615.00

Date Type Amount Purchased Purchaser
2023-11-30 Sale -43443.00 Tak Paul Peter
2023-11-30 Sale -12175.00 Nichols William Garrett
2023-11-30 Sale -17328.00 Tyagarajan Seshu
2023-11-30 Sale -19748.00 Barone Francesca
2023-11-30 Sale -20153.00 Amello Jason
2023-11-28 Sale -112790.00 Barone Francesca
2023-11-28 Sale -88822.00 Nichols William Garrett
2023-11-28 Sale -104516.00 Tyagarajan Seshu
2023-11-28 Sale -125717.00 Amello Jason
2023-11-28 Sale -180108.00 Tak Paul Peter

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Apr 02, 2026
4 Insider transactions 1 Apr 02, 2026
4 Insider transactions 1 Apr 02, 2026
schedule Other 2 Mar 18, 2026
s-8 Registration statements 15 Mar 12, 2026
8-k 8K-related 12 Mar 12, 2026
10-k Annual reports 97 Mar 12, 2026
4 Insider transactions 1 Feb 26, 2026
8-k 8K-related 19 Feb 23, 2026
424b5 Other 3 Feb 20, 2026

Latest News


× Before browsing our site, please accept our cookies policy